Amyloidosis-Associated Kidney Disease
Top Cited Papers
Open Access
- 1 December 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 17 (12) , 3458-3471
- https://doi.org/10.1681/asn.2006050460
Abstract
The amyloidoses are a group of disorders in which soluble proteins aggregate and deposit extracellularly in tissues as insoluble fibrils, causing progressive organ dysfunction. The kidney is one of the most frequent sites of amyloid deposition in AL, AA, and several of the hereditary amyloidoses. Amyloid fibril formation begins with the misfolding of an amyloidogenic precursor protein. The misfolded variants self-aggregate in a highly ordered manner, generating protofilaments that interact to form fibrils. The fibrils have a characteristic appearance by electron microscopy and generate birefringence under polarized light when stained with Congo red dye. Advances in elucidating the mechanisms of amyloid fibril formation, tissue deposition, and tissue injury have led to new and more aggressive treatment approaches for these disorders. This article reviews the pathogenesis, diagnosis, clinical manifestations, and treatment of the amyloidoses, focusing heavily on the renal aspects of each of these areas.Keywords
This publication has 100 references indexed in Scilit:
- Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rateBone Marrow Transplantation, 2004
- Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantationBlood, 2004
- Spontaneous rupture of the spleen in AL amyloidosisAmerican Journal of Hematology, 2003
- Therapeutic strategies for human amyloid diseasesNature Reviews Drug Discovery, 2002
- An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosisBone Marrow Transplantation, 2001
- High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosisBone Marrow Transplantation, 2001
- Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A proteinThe Lancet, 2001
- Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patientsBritish Journal of Haematology, 1998
- Adult fanconi syndrome in primary amyloidosis with lambda light-chain proteinuria.Japanese Journal of Medicine, 1989
- Persistent Water Diuresis in Renal AmyloidosisScandinavian Journal of Urology and Nephrology, 1981